Biogen

Yahoo Finance • 2 days ago

Biogen Faces Uncertain Outlook for Alzheimer's Drug But Pipeline Supports Growth, RBC Says

Biogen's (BIIB) new Alzheimer's drug, BIIB080, has mid-year results coming up and its success is unc PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 days ago

Personalized Medicine Market Competitive Landscape Report 2025: Company Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Company Logo Personalized Medicine Market Poised for Tremendous Growth by 2033The global personalized medicine market, valued at approximately US$ 585.53 billion in 2026, is projected to soar to nearly US$ 1.00 trillion by 2033. A report... Full story

Yahoo Finance • 9 days ago

Barclays launches U.S. biopharma coverage with four preferred picks

Investing.com -- Barclays launched coverage of U.S. large-cap biopharmaceutical companies, arguing the sector could regain investor attention in an uncertain macro backdrop, while naming Eli Lilly (NYSE:LLY), Merck (NYSE:MRK), Bristol-Myer... Full story

Yahoo Finance • 15 days ago

Wedbush Lifts PT on Biogen Inc. (BIIB) to $187 From $178 – Here’s Why

Biogen Inc. (NASDAQ:BIIB) is one of the best medical research stocks to buy according to hedge funds. On February 10, Wedbush lifted the price target on Biogen Inc. (NASDAQ:BIIB) to $187 from $178, maintaining a Neutral rating on the share... Full story

Yahoo Finance • 17 days ago

Biogen Announces Board Chair Transition

CAMBRIDGE, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the Board of Directors has elected Dr. Maria C. Freire as Chair of the Board of Directors, effective immediately following the Company’s... Full story

Yahoo Finance • 19 days ago

Precision Medicine Analysis Report 2026: A $237.28 Billion Market by 2031 - Strategic Pharma-Big-Tech Alliances Speeding Precision Drug Discovery

Dublin, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The "Precision Medicine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" report has been added to ResearchAndMarkets.com's offering. The Precision Medicine... Full story

Yahoo Finance • 19 days ago

Global Gene Therapy and CRISPR Market Shows Billion Dollar Growth with Novartis Zolgensma 1.2 Billion Sarepta Elevidys 611 Million and Emerging CRISPR Collaborations 20 Million

Precedence Research Precedence Research, a leading strategic research firm, today released a comprehensive overview of the gene therapy and CRISPR therapeutics market, highlighting key company performance, pipeline developments, and gover... Full story

Yahoo Finance • 20 days ago

Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Designated for Priority Review in China

TOKYO and CAMBRIDGE, Mass., Feb. 08, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbache... Full story

Yahoo Finance • 20 days ago

Biogen Hits 52-Week High, Alzheimer's Drug Sales Jump

Biogen Inc.(NASDAQ:BIIB) on Friday reported better-than-expected fourth-quarter earnings, with adjusted EPS of $1.99, beating the consensus of $1.59. The Alzheimer's drug maker reported revenues of $2.28 billion, beating the consensus of... Full story

Yahoo Finance • 22 days ago

Why Biogen Stock Surged Almost 9% Higher on Friday

Key Points The biotech published its last set of financials for 2025. Its quarterly revenue and adjusted profitability declined, yet both still topped the consensus analyst estimates.10 stocks we like better than Biogen › One of the heal... Full story

Yahoo Finance • 22 days ago

Stocks Rebound on Positive Tech Earnings

The S&P 500 Index ($SPX) (SPY) today is up +1.20%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +1.48%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.26%.  March E-mini S&P futures (ESH26) are up +1.21%, and March E-mini Nasdaq fu... Full story

Yahoo Finance • 23 days ago

Sales of Leqembi® totaled 20.7 billion yen in the fourth quarter 2025

STOCKHOLM, Feb. 6, 2026 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today published the preliminary global revenue for Leqembi for the fourth quarter 2025, in conjunction with their partner Biogen's fourt... Full story

Yahoo Finance • 23 days ago

US Stock Market Today: S&P 500 Futures Slip As Growth Jitters Offset Softer Yields

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. The Morning Bull - US Market Morning Update Friday, Feb, 6 2026 U... Full story

Yahoo Finance • 23 days ago

Stocks Settle Lower as Tech and Crypto are Routed

The S&P 500 Index ($SPX) (SPY) on Thursday closed down -1.23%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -1.20%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -1.38%.  March E-mini S&P futures (ESH26) fell -1.23%, and... Full story

Yahoo Finance • 23 days ago

Under Armour earnings, Fed, Liftoff Mobile IPO: What to Watch

Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Friday, February 6, including earnings results from Under Armour (UAA, UA), Biogen (BIIB), and Philip Morris (PM); commentary from Federa... Full story

Yahoo Finance • 23 days ago

Pre-Market Earnings Report for February 6, 2026 : PM, CBOE, BIIB, AER, CG, CNC, NVT, ROIV, PAA, AN, MKTX, PIPR

The following companies are expected to report earnings prior to market open on 02/06/2026. Visit our Earnings Calendar for a full list of expected earnings releases. Philip Morris International Inc (PM)is reporting for the quarter end... Full story

Yahoo Finance • 23 days ago

Biogen Q4 2025 Earnings Preview

* Biogen (BIIB [https://seekingalpha.com/symbol/BIIB]) is scheduled to announce Q4 earnings results on Friday, February 6th, before market open. * The consensus EPS Estimate is $1.63 [https://seekingalpha.com/symbol/BIIB/earnings/estim... Full story

Yahoo Finance • 25 days ago

Nature Medicine Publishes Results from the Pivotal DEVOTE Study of High-Dose Regimen of Nusinersen in Spinal Muscular Atrophy

Findings from DEVOTE support clinical benefits of the high-dose regimen of nusinersen (50 mg and 28 mg) in both treatment-naïve individuals and those previously treated with 12 mg nusinersenThe high-dose regimen of nusinersen also slowed n... Full story

Yahoo Finance • 25 days ago

Big Tech and Pharma Earnings: What to Watch This Week

Earnings season marches on. Two more Magnificent Seven tech companies—Alphabet and Amazon—will report, following on the heels of disappointing results from Microsoft that helped send software stocks tumbling last week. Continue Reading... Full story

Yahoo Finance • 25 days ago

These Are The Worst 25 Stocks to Own in February

It's been an interesting start to the year, with plenty of geopolitical developments for investors to unpack. The market managed monthly wins in January, but as we get into February, it's not a bad idea to keep an eye on stocks that have h... Full story